INCERTI, Matteo
 Distribuzione geografica
Continente #
EU - Europa 3.455
NA - Nord America 3.346
AS - Asia 1.632
AF - Africa 42
SA - Sud America 14
OC - Oceania 2
Totale 8.491
Nazione #
US - Stati Uniti d'America 3.288
CN - Cina 1.007
IT - Italia 790
IE - Irlanda 640
FI - Finlandia 582
SE - Svezia 558
SG - Singapore 458
DE - Germania 313
UA - Ucraina 300
TR - Turchia 97
GB - Regno Unito 61
CA - Canada 58
FR - Francia 57
AT - Austria 42
BE - Belgio 37
CI - Costa d'Avorio 36
IN - India 35
CZ - Repubblica Ceca 18
GR - Grecia 18
BR - Brasile 12
HU - Ungheria 11
HK - Hong Kong 8
JP - Giappone 7
LT - Lituania 7
KR - Corea 5
NL - Olanda 5
VN - Vietnam 4
NP - Nepal 3
ZA - Sudafrica 3
AL - Albania 2
AU - Australia 2
ES - Italia 2
IR - Iran 2
NG - Nigeria 2
NO - Norvegia 2
RO - Romania 2
RU - Federazione Russa 2
AR - Argentina 1
BG - Bulgaria 1
BY - Bielorussia 1
CH - Svizzera 1
CO - Colombia 1
HR - Croazia 1
IQ - Iraq 1
KH - Cambogia 1
MY - Malesia 1
PK - Pakistan 1
RS - Serbia 1
SI - Slovenia 1
TN - Tunisia 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 8.491
Città #
Dublin 639
Chandler 551
Santa Clara 370
Singapore 365
Jacksonville 346
Parma 282
Beijing 265
Ann Arbor 251
Dearborn 185
Ashburn 166
Boardman 165
Nanjing 153
Shanghai 109
Princeton 108
Izmir 88
Wilmington 83
San Mateo 79
New York 71
Bremen 66
Helsinki 54
Shenyang 49
Toronto 49
Kunming 44
Vienna 41
Hefei 40
Grafing 39
Abidjan 36
Hebei 36
Nanchang 36
Chicago 35
Jinan 35
Brussels 31
Des Moines 28
Guangzhou 28
Bologna 24
Woodbridge 22
Jiaxing 21
Los Angeles 20
Rome 20
Seattle 20
Pune 19
Tianjin 19
Milan 18
Modena 18
Changsha 16
Fremont 14
Houston 14
Dallas 13
Hangzhou 13
Munich 13
Brno 12
Norwalk 12
Zhengzhou 12
Brescia 10
Düsseldorf 10
Athens 9
Frankfurt am Main 9
London 9
Fuzhou 8
Kavala 8
Ottawa 8
Taizhou 8
Haikou 7
Ningbo 7
Paris 7
Taiyuan 7
Auburn Hills 6
Borås 6
Chengdu 6
Palermo 6
Pesaro 6
Solaro 6
Ankara 5
Carpi 5
Castello Molina di Fiemme 5
Hyderabad 5
Prata Di Pordenone 5
Redwood City 5
Altidona 4
Budapest 4
Lanzhou 4
Leuven 4
Lubbock 4
Montecchio Emilia 4
Piacenza 4
Reggio Emilia 4
Reggio Nell'emilia 4
Sant'ilario D'enza 4
Springfield 4
Tulsa 4
Vigevano 4
Wenzhou 4
Xian 4
Albignasego 3
Bisceglie 3
Caorso 3
Carrara 3
Compiano 3
Finale Emilia 3
Fiorenzuola d'Arda 3
Totale 5.497
Nome #
Hydroxyphenyl thiosemicarbazones as inhibitors of mushroom tyrosinase and antibrowning agents. 181
Inhibition of Eph/ephrin interaction with the small molecule UniPR500 improves glucose tolerance in healthy and insulin-resistant mice 165
Effetto di derivati dell'urea sulla radicazione avventizia in vitro di microtalee micropropagate di corbezzolo 142
UniPR129 is a competitive small molecule Eph-ephrin antagonist blocking in vitro angiogenesis at low micromolar concentrations. 140
A New ABCB1 Inhibitor Enhances the Anticancer Effect of Doxorubicin in Both In Vitro and In Vivo Models of NSCLC 137
Optimization of EphA2 antagonists based on a lithocholic acid core led to the identification of UniPR505, a new 3α-carbamoyloxy derivative with antiangiogenetic properties 134
inibitori eph-ephrin biodisponibili oralmente 130
Pharmacological evaluation of new bioavailable small molecules targeting Eph/ephrin interaction 126
Bithiazole Inhibitors of Phosphatidylinositol 4-Kinase (PI4KIIIβ) as Broad-Spectrum Antivirals Blocking the Replication of SARS-CoV-2, Zika Virus, and Human Rhinoviruses 124
Lithocholic acid is an Eph-ephrin ligand interfering with Eph-kinase activation 117
Development of an orally bioavailable small molecule targeting Eph-ephrin system: in vitro and in vivo anticancer activity. 115
Effect of Cl-Substitution on Rooting- or Cytokinin-like Activity of Diphenylurea Derivatives 110
Adventitious rooting adjuvant activity of 1,3-di(benzo[d]oxazol-5-yl) urea and 1,3-di(benzo[d]oxazol-6-yl)urea: new insights and perspectives 109
Combining ligand- and structure-based approaches for the discovery of new inhibitors of the EPHA2-ephrin-A1 interaction 107
Probucol treatment is associated with an ABCA1-independent mechanism of cholesterol efflux to lipid poor apolipoproteins from foam cell macrophages 106
Metabolic Soft Spot and Pharmacokinetics: Functionalization of C-3 Position of an Eph–Ephrin Antagonist Featuring a Bile Acid Core as an Effective Strategy to Obtain Oral Bioavailability in Mice 105
New MDR1 inhibitors for overcoming multidrug resistance 100
A new efficient route to 7-aryl-6-fluoro-8-nitroquinolones as potent antibacterial agents 99
Structure–Activity Relationships and Mechanism of Action of Eph–ephrin Antagonists: Interaction of Cholanic Acid with the EphA2 Receptor 99
2-Benzo[d]isothiazolylimino-5-arylidene-4-thiazolidinones: Synthesis and antimicrobial activity 98
Design and structure-activity relationship of amino acid derivatives of lithocholic acid as novel EphA2 antagonists 97
A one-pot PPh3-promoted synthesis of new functionalized heterocycles derived from 2-aminobenzo[d]isothiazol-3-one 96
4-Chloro-N-(4-chlorophenylsulfonyl)-N-(3-oxo-2,3-dihydro-1,2-benzisothiazol-2-yl)benzenesulfonamide 92
Discovery and development of small molecules targeting Eph-ephrin system in glioblastoma: an academic history 92
Amino acid conjugates of lithocholic acid as antagonists of the EphA2 receptor. 90
Development of 3-oxo-cholenic derivatives as Eph antagonists able to block in vitro angiogenesis 89
Discovery and development of Eph-ephrin antagonists endowed with antiangiogenic properties 88
Eph/ephrin targeting with a small molecule improves glucose tolerance in healthy and insulin-resistant mice 87
Multiple approaches for the discovery and development of small molecules targeting Eph-ephrin protein-protein interaction 85
Amidinobenzisothiazole derivatives with antidegenerative activity on cartilage 83
Comparative Analysis of Virtual Screening Approaches in the Search for Novel EphA2 Receptor Antagonists 82
Diheteroarylurea derivatives as adventitious rooting adjuvants in mung bean shoots and M26 apple rootstock. 81
Complete 1H and 13C NMR spectral assignment of benzo[d]isothiazole derivatives and of an isoindole isoster 81
Design and structure-activity relationships of amino acid derivatives of lithocholic acid as novel EphA2 receptor antagonists. 81
Metadynamics for perspective drug design: Computationally driven synthesis of new protein-protein interaction inhibitors targeting the EphA2 receptor 81
Combining pharmacology, target hopping and computational medicinal chemistry to discover novel scaffold targeting EPH-ephrin interaction. 80
Synthesis and NMR spectral assignments of novel 1,4-benzothiazepine-5-one derivatives 78
Dual-Acting Drugs: an in vitro Study of Nonimidazole Histamine H(3) Receptor Antagonists Combining Anticholinesterase Activity 78
Target Hopping as a Useful Tool for the Identification of Novel EphA2 Protein–Protein Antagonists 78
Synthesis and antimicrobial properties of 2-(benzylidene -amino)-benzo[d]isothiazol-3-ones 77
270 Discovery, development and optimization of low molecular weight EPH–ephrin protein–protein inhibitors 77
Discovery and development of low molecular weight Eph-ephrin protein-protein inhbi-tors endowed with antiangiogenic activity 77
Aminoderivatives of benzothiazole/benzisothiazole heterocycles as intermediates in the synthesis of novel therapeutic agents 76
A ONE-POT ENTRY TO A NOVEL 3-H-BENZO[D]PYRAZOLO[1,5-B]ISOTHIAZOLE RING SYSTEM. 75
2-Benzisothiazolylimino-5-benzylidene-4-thiazolidinones as protective agents against cartilage destruction 75
Evaluation of the anti-tumor activity of small molecules targeting eph/ephrins in apcmin j mice 75
A potentiometric and spectrofluorimetric approach to unravel inhibitory effects of semi- and thiosemicarbazones on mushroom tyrosinase activity 74
Structure activity relationship of new EphA2 ligands 74
2-Heteroarylimino-5-benzylidene-4-thiazolidinones analogues of 2-thiazolylimino-5-benzylidene-4-thiazolidinones with antimicrobial activity: synthesis and structure-activity relationship. 74
Probing the effects of MR120 in preclinical chronic colitis: A first-in-class anti-IBD agent targeting the CCL20/CCR6 axis 73
Synthesis and antimicrobial properties of benzothiazole benzenesulfonamides 73
2-Benzisothiazolylimino-5-benzylidene-4-thiazolidinones as protective agents against cartilage destruction. 73
4-Methyl-N-(3-oxo-2,3-dihydro-1,2-benzisothiazol-2-yl)benzenesulfonamide 73
Biochemical characterization of EphA2 antagonists with improved physico-chemical properties by cell-based assays and surface plasmon resonance analysis 73
Anti-HIV evaluation of benzo[d]isothiazole hydrazones. 72
Design synthesis and antibacterial activity studies of new thiadiazoloquinolone compounds 71
Thiazolyl and isothiazolyl azomethine derivatives with antiinflammatory and antioxidant activities. Synthesis, biological evaluation and structure activity relationships study 71
Structure-activity relationships of N-phenyl-N’-benzothiazol-6-ylurea synthetic derivatives: cytokinin-like activity and adventitious rooting enhancement 71
Attività antiproliferativa di N-(1,2-benzisothiaziol-3-il)benzaamidine su cellule di carcinoma colon-rettale umano 70
Δ5-Cholenoyl-amino acids as selective and orally available antagonists of the Eph-ephrin system 70
Lithocholic acid competitively inhibits EphA2-ephrinA1 binding: pharmacological and structural considerations. 69
Exploiting Free-Energy Minima to Design Novel EphA2 Protein-Protein Antagonists: From Simulation to Experiment and Return 69
On the Use of 2,5-Dimethyl-Pyrrol-1-yl-Benzoic Acid Derivatives as EPH-Ephrin Antagonists. 69
Synthesis and pharmacological properties of benzisothiazole/benzimidazole derivatives with acidic groups 69
Multi-target-directed ligands: new histamine H3 receptor antagonists with anticholinesterase activity 69
Benzisothiazolylimino-5-benzylidene-4-thiazolidinones as potential biologically active agents 69
A one-pot PPh3-promoted synthesis of new functionalized heterocycles derived from 2-aminobenzo[d]isothiazol-3-one 68
Lithocholic acid competitively inhibitis EphA2-ephrinA1 binding: pharmacological and structural considerations. 68
Lithocholic Acid Is an Eph-ephrin Ligand Interfering with Eph-kinase Activation. 68
Heterocycles [h]-fused to 4-oxoquinoline-3-carboxylic acid. Part XI: Synthesis and antibacterial activity of 4-fluoro-6-oxoimidazo[4,5-h]quinoline-7-carboxylic acids 68
Synthesis and biological evaluation of benzo[d]isothiazole, benzothiazole and thiazole Schiff bases 67
Antidegenerative activity of heteroarylimino-4-thiazolidinones on human chondrocyte cultures stimulated by IL-1ß 67
Weakly cytokinin-active diphenylurea derivatives influence adventitious rooting in M26 Malus pumila microcuttings 67
4-thiazolidinone derivatives as MMP inhibitors in tissue damage: Synthesis, biological evaluation and docking studies 65
2-BENZO[d]ISOTHIAZOLYLIMINO-5-ARYLIDENE-4-THIAZOLIDINONES: SYNTHESIS AND ANTIMICROBIAL ACTIVITY 65
QSAR analysis of 4-thiazolidinone derivatives with antimicrobial activity. 63
Synthesis and antiproliferative activity of novel benzo[d]isothiazole compounds bearing a 2,4-dinitrophenyl group. 62
Computer-Aided Design of Novel Antagonists of the EphA2 Receptor 62
Are we using the right pharmacological tools to target EphA4? 62
Stereospecific effects of benzo(d)isothiazolyloxypropanolamine derivatives at beta-adrenoceptors: synthesis, chiral resolution, and biological activity in vitro 62
Benzisothiazolyliminothiazolidin-4-ones with chondroprotective properties: searching for potent and selective inhibitors of MMP-13. 62
Synthesis and Structure-Activity Relationships of Amino Acid Conjugates of Cholanic Acid as Antagonists of the EphA2 Receptor. 61
Synthesis of benzisoxazole and benzisothiazole derivatives with potential antitumor activity 59
Investigation of the reaction between 3-benzisothiazolones, an isoindole isoster and activated acetylenes: synthesis of novel heterocyclic backbones for building bioactive molecules 59
In vitro and in vivo efficacy of an orally bioavailable antagonist of Eph-ephrin system in tumor angiogenesis and growth 59
Target-hopping: a useful approach to identify novel Eph receptor antagonists 58
Synthesis and biological activity of hydrazones of benzo[d]isothiazole hydrazides 58
Effects of a dietary intervention with Mediterranean vs lacto-ovo vegetarian diets on HDL function: results from the CARDIVEG study 57
Lipophilicity estimation of new benzisothiazolone derivatives with anti HIV-1 activity for a rational study of structure-activity relationship 57
Molecular modeling of binding between amidinobenzisothiazoles, with antidegenerative activity on cartilage, and matrix metalloproteinase-3 55
Benzo[d]isothiazol-3-yl-benzamidines: a class of protective agents on culture of human cartilage and chondrocytes stimulated by IL-1ß. 53
Synthesis and evaluation as antimicrobial agents of novel heteroaryl sulfonamides 53
Evaluation of the antiproliferative activity of benzofused nitrogen and sulfur/oxygen containig heterocycles derivatives 53
Synthesis and antimicrobial activity of benzylidene derivatives of 2-(benzo[d]thiazol-2-ylimino)thiazolidin-4-one 52
Synthesis of novel 5-arylidene-thiazol-4-ones 2-heteroarylamino substituted as potential antimicrobials 51
Hybrid molecules between benzenesulfonamides and active antimicrobial benzo[d]isothiazol-3-ones. 51
Synthesis and biological evaluation of tetracyclic thienopyridones as antibacterial and antitumor agents 51
Targeting Eph/ephrin system in cancer therapy 50
Nucleoside Derivatives of 2,6-Diaminopurine Antivirals: Base-Modified Nucleosides with Broad-Spectrum Antimicrobial Properties 49
Benzo[d]isothiazol-3-yl-benzamidines : a new class of protective agents on culture of human chondrocytes stimulated by IL-1B 49
Totale 8.032
Categoria #
all - tutte 31.790
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.790


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020627 0 0 0 0 0 0 179 42 160 134 32 80
2020/2021784 20 78 76 56 104 29 95 24 127 44 100 31
2021/2022674 24 15 20 70 24 55 70 87 37 55 25 192
2022/20232.326 245 261 126 169 217 240 44 145 763 20 62 34
2023/2024858 56 64 40 23 60 191 95 65 20 36 68 140
2024/20251.200 92 166 189 150 305 298 0 0 0 0 0 0
Totale 8.658